Great Point Partners LLC 13F holdings, Q3 2025
Holdings as of September 30, 2025 · filings on SEC EDGAR · latest filing →
Great Point Partners LLC disclosed 28 US equity positions worth $239.5m in its Q3 2025 13F filing. The largest position was AMLX at 9.6% of the reported book, followed by RZLT and NKTR. Against the Q2 2025 filing, it opened 10 new positions, added to 4 and reduced 6 among the top 28 holdings.
What did Great Point Partners LLC own in Q3 2025? Top 28 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q2 2025 |
|---|---|---|---|---|---|---|---|
| 1 | AMLX AMYLYX PHARMACEUTICALS INC | Healthcare | 9.6% | $23.1m | 1,700,000 | -15% | reduced |
| 2 | RZLT REZOLUTE INC COM NEW | 9.6% | $23.0m | 2,451,809 | -19% | reduced | |
| 3 | NKTR NEKTAR THERAPEUTICS COM NEW | Healthcare | 7.1% | $17.1m | 300,000 | – | new |
| 4 | ZURA ZURA BIO LTD CLASS A ORD SHS | Healthcare | 6.9% | $16.5m | 3,815,930 | 20% | added |
| 5 | SLNOEUR SOLENO THERAPEUTICS INC | 6.4% | $15.2m | 225,000 | – | new | |
| 6 | ASND ASCENDIS PHARMA A/S SPONSORED ADR | Healthcare | 6.2% | $14.9m | 75,000 | – | new |
| 7 | ABVX ABIVAX SA SPONSORED ADS | 5.3% | $12.7m | 150,000 | -88% | reduced | |
| 8 | APGE APOGEE THERAPEUTICS INC | Healthcare | 5.0% | $12.1m | 304,000 | – | new |
| 9 | DNTH DIANTHUS THERAPEUTICS INC | Healthcare | 4.4% | $10.5m | 265,803 | – | new |
| 10 | CYTK CYTOKINETICS INC COM NEW | Healthcare | 3.4% | $8.2m | 150,000 | 0% | held |
| 11 | IMVT IMMUNOVANT INC | Healthcare | 3.4% | $8.1m | 500,000 | 91% | added |
| 12 | XENE XENON PHARMACEUTICALS INC | Healthcare | 3.4% | $8.0m | 200,000 | 0% | held |
| 13 | NGNE NEUROGENE INC | 3.2% | $7.7m | 446,814 | -8% | reduced | |
| 14 | EPRX EUPRAXIA PHARMACEUTICALS INC | 3.0% | $7.1m | 1,200,000 | – | new | |
| 15 | UPB UPSTREAM BIO INC | 2.4% | $5.6m | 300,000 | 0% | held | |
| 16 | JBIO JADE BIOSCIENCES INC COM NEW | 2.3% | $5.5m | 632,599 | 27% | added | |
| 17 | IONS IONIS PHARMACEUTICALS INC | Healthcare | 2.2% | $5.2m | 80,000 | -84% | reduced |
| 18 | AKERO THERAPEUTICS INC | 2.1% | $4.9m | 103,848 | 0% | held | |
| 19 | TSHA TAYSHA GENE THERAPIES INC COM SHS | Healthcare | 2.0% | $4.9m | 1,500,000 | 0% | held |
| 20 | CNTX CONTEXT THERAPEUTICS INC | 1.9% | $4.5m | 4,683,711 | 0% | held | |
| 21 | PHVS PHARVARIS N V | 1.6% | $3.9m | 155,105 | – | new | |
| 22 | DBVT DBV TECHNOLOGIES S A SPONSORED ADS | 1.6% | $3.8m | 378,594 | 1% | added | |
| 23 | LEGN LEGEND BIOTECH CORP SPONSORED ADS | Healthcare | 1.5% | $3.7m | 113,460 | -68% | reduced |
| 24 | ORKA ORUKA THERAPEUTICS INC | Healthcare | 1.5% | $3.5m | 183,330 | – | new |
| 25 | UNCY UNICYCIVE THERAPEUTICS INC COM NEW | 1.4% | $3.5m | 796,558 | 0% | held | |
| 26 | SANA SANA BIOTECHNOLOGY INC | Healthcare | 1.0% | $2.5m | 700,000 | – | new |
| 27 | ABSI ABSCI CORPORATION | 1.0% | $2.4m | 796,438 | – | new | |
| 28 | PLRX PLIANT THERAPEUTICS INC | Healthcare | 0.5% | $1.3m | 850,000 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.